US Institute of Medicine calls for major changes at FDABMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7570.673 (Published 28 September 2006) Cite this as: BMJ 2006;333:673
- Janice Tanne
- New York
The US Institute of Medicine last week called for fundamental changes to the country's Food and Drug Administration to improve drug safety. Its report says that the agency should be funded better and that a greater emphasis on post-marketing surveillance is needed.
The report also calls for the FDA's culture and management and its system of funding to be changed. Some of the agency's income comes from user fees paid by drug companies.
It says, “Recent drug safety events have called into question FDA's regulatory decision making and oversight processes, and caused the public to question its ability to accomplish a balanced evaluation of safety and efficacy of the drugs it reviews …
Log in using your username and password
Log in through your institution
Sign up for a free trial